.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent breakthroughs in molecular oncology have highlighted the critical role of metabolic reprogramming in tumor survival. Specifically, FABP5 cervical cancer resistance has emerged as a significant barrier to effective chemotherapy. A study by Zhang T et al. investigated Fatty acid-binding protein 5 (FABP5) to determine its clinical value as a treatment target. The research utilized advanced bioinformatics and immunohistochemistry to analyze expression patterns in cervical squamous cell carcinoma (CESC).
The experimental results demonstrated that FABP5 overexpression markedly increases the proliferation and invasion of cervical cancer cells. Furthermore, this protein confers resistance to the cytotoxic effects of common drugs like cisplatin and paclitaxel. RNA sequencing and lipid staining revealed that FABP5 plays a central role in cellular metabolism. By inhibiting the PPARγ/CPT1A and ATP5A1 signaling pathways, FABP5 effectively boosts energy reserves while maintaining a low-ROS (reactive oxygen species) state. Cells then survive drug-induced stress more effectively because they mitigate the toxicity typically caused by fatty acid oxidation.
Targeting the PPARγ/CPT1A signaling pathway may provide a way to overcome drug resistance. Experimental data shows that exogenous drugs can activate these suppressed pathways. This activation reduces energy reserves and increases drug-induced oxidative stress. Consequently, FABP5 stands out as a promising target for future pharmaceutical interventions in oncology. Understanding these metabolic mechanisms allows clinicians to better predict patient responses to standard chemotherapeutic regimens. Moreover, these findings suggest that combining metabolic inhibitors with standard care could improve outcomes for advanced cervical cancer patients.
FABP5 suppresses the PPARγ/CPT1A pathway, which reduces ROS production and increases cellular energy reserves. This metabolic shift allows cancer cells to survive chemotherapy drugs like cisplatin and paclitaxel.
Chemotherapy typically kills cancer cells by inducing toxic levels of reactive oxygen species (ROS). FABP5 inhibits fatty acid β-oxidation, which lowers ROS levels and protects the cancer cells from treatment-induced damage.
Research suggests that inhibiting FABP5 or reactivating the PPARγ/CPT1A pathway could restore drug sensitivity, making chemotherapy more effective against resistant cervical cancer cell lines.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
1. Zhang T et al. FABP5 confers resistance to drug-induced ROS toxicity in cervical cancer cell lines by suppressing the PPARγ/CPT1A signaling pathway. Discov Oncol. 2026 May 25. doi: 10.1007/s12672-026-05268-7. PMID: 42184092.
2. Zhang X, et al. FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism. Theranostics. 2020;10(15):6561-6580. doi: 10.7150/thno.44868.
3. Qian J, et al. USP14 targets FABP5-mediated ferroptosis to promote proliferation and cisplatin resistance of HNSCC. Front Pharmacol. 2023;14:1150861. doi: 10.3389/fphar.2023.1150861.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research shows that FABP5 suppresses the PPARγ/CPT1A pathway, boosting energy and lowering ROS to resist chemotherapy in cervical cancer cells....
2 months ago
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
